Effects of ICS + LABA Combination Therapy on Asthma Control: An Observational Study in Real-World Settings
Therapeutics and Clinical Risk Management · 2026-02 · Volume 22 · 1-9
DOI: 10.2147/tcrm.s547261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2026-02. Verfasst von Ping Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Wuhan Hankou Hospital, Wuhan, Hubei, People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Wuhan Hankou Hospital, Wuhan, Hubei, People's Republic of China.
- Department of Respiratory and Critical Care Medicine, Wuhan Dongxihu District People's Hospital, Wuhan, Hubei, People's Republic of China.
Zitieren
APA
Han, P., & Wang, L. (2026). Effects of ICS + LABA Combination Therapy on Asthma Control: An Observational Study in Real-World Settings. Therapeutics and Clinical Risk Management, Volume 22, 1-9. https://doi.org/10.2147/tcrm.s547261
Vancouver
Han P, Wang L. Effects of ICS + LABA Combination Therapy on Asthma Control: An Observational Study in Real-World Settings. Therapeutics and Clinical Risk Management. 2026;Volume 22:1-9. doi:10.2147/tcrm.s547261
BibTeX
@article{Han2026,
author = {Han, Ping and Wang, Lihua},
title = {Effects of ICS + LABA Combination Therapy on Asthma Control: An Observational Study in Real-World Settings},
journal = {Therapeutics and Clinical Risk Management},
year = {2026},
volume = {Volume 22},
pages = {1--9},
doi = {10.2147/tcrm.s547261}
}
EUVIMED